Diskussion zur BICO Group Aktie WKN: A2PX00 ISIN: SE0013647385 Forum: Aktien User: Hedgehog3

Gibt es schon Infos?

bin mal gespannt, in 2h wissen wir mehr :) hoffe mal das die 40eur wieder geknackt wird

Market day... Hoffentlich hauen die gute Prognosen raus! Das würde evtl. abschieben!

So ist es! Die 🇸🇪 reagieren null auf 🇺🇸!

Der Ami-Markt ist hier für mich nicht entscheidend, sondern eher, wie Stockholm reagiert/ endet. Nachher noch: CELLINK DIGITAL CAPITAL MARKETS DAY https://www.cellink.com/investors/cellink-digital-capital-market-day/

Korb steht bei 35, vllt hauen die Amis nochmal drauf

Bin auch eingestiegen

Jetzt sehen wir vielleicht doch noch die 37!

Warum sollen die Zahlen schlecht sein? Weil Ergebnis Negativ? 241% Umsatzanstieg, davon 62% aus eigener Kraft. Sieht für mich gut aus. Ich habe nachgekauft 😬

Nein. Zahlen sind top.

Schlecht die Zahlen

Jetzt bald wieder nachkauf kurse

Was ist denn jetzt los?!

Oh oh 📉

Danke, Bärenfutter! Noch der Link: https://www.cellink.com/investors/press-release/?r=72006A58AC21D33B

First quarter, 2021 Net sales amounted to MSEK 129.5 (38.0), which corresponded to an increase of 241% (55) compared to the corresponding period previous year, of which 62% (25) was organic growth. Operating profit before depreciation (EBITDA) amounted to MSEK -34.9 (-5.7), corresponding to a margin of -26.9% (-14.9). The operating profit during the quarter was affected by acquisition costs totaling MSEK 20.5. Profit/loss for the period amounted to MSEK -47.8 (-33.5), which generated earnings per share after dilution of SEK -0.90 (-0.80). The result was positively affected by the market valuation of the company's short-term investments of MSEK 4.4 (-22.7). The gross margin amounted to 77.3% (74.8), mainly due to higher revenue per product, improved product mix and increased share of sales in services and consumables. Rolling twelve-month net sales from consumables amounted to MSEK 46.2 (19.2), an increase of 140%. The share of total product sales was 12.9%, a decrease of 0.2 percentage points (13.1% in the comparison period). During the quarter, the Finnish company Ginolis, specializing in advanced diagnostics automation and advanced robotics solutions, was acquired for MSEK 648.8. In addition, the American company MatTek, a global leader in in-vitro technology and alternative drug testing models for pharmaceuticals and cosmetic products, was acquired for MSEK 610. During March, the offering of senior unsecured convertible bonds convertible to Class B share and a class B share issue to a total amount of MDSEK 3 were completed.